Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative Neoplasms
Status:
Not yet recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of captopril and
evaluate the effectiveness captopril as measured by changes in the grade of bone marrow scar
tissue. The change in spleen size by ultrasound will also be measured.